Federal Judge Dismisses Class-Action Lawsuit Challenging Nexium Marketing

Drug Industry Daily
KEYWORDS Advertising / Markets
A A

A class-action lawsuit accusing AstraZeneca of waging a misleading promotional campaign to deceive patients into buying its heartburn drug Nexium was dismissed this week in a Delaware federal court.

To View This Article:

Login

Subscribe To Drug Industry Daily